Resumen
Soluble tweak protein as an early marker of cardiovascular disease. It refers to the use of soluble tweak (stweak) as an early biomarker of a cardiovascular disease and/or to predict the evolution of a cardiovascular disorder or event and/or to evaluate the effectiveness of a reducing treatment for a cardiovascular event or disorder, as well as to a method for the quantification of the stweak and a kit capable of carrying out said method. (Machine-translation by Google Translate, not legally binding)